1 Artzi O, Sinai M, Solomon M, Schwartz E. Recurrent furunculosis in returning travelers: newly defined entity. J Travel Med. 2015;22(1):21–5.
2 Nurjadi D, Friedrich-Jänicke B, Schäfer J, Van Genderen PJ, Goorhuis A, Perignon A, et al. Skin and soft tissue infections in intercontinental travellers and the import of multi- resistant Staphylococcus aureus to Europe. Clin Microbiol Infect. 2015;21(6):567.e1-10.
3 Jaton L, Pillonel T, Jaton K, Dory E, Prod’hom G, Blanc DS, et al. Common skin infection due to Panton-Valentine leucocidin-producing Staphylococcus aureus strains in asylum seekers from Eritrea: a genome-based investigation of a suspected outbreak. Clin Microbiol Infect. 2016;22(8):739.e5–8.
4 Meinel DM, Kuehl R, Zbinden R, Boskova V, Garzoni C, Fadini D, et al. Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing. Clin Microbiol Infect. 2016;22(12):1003.e1–1003.e8.
5 Kolios AGA, Cozzio A, Zinkernagel AS, French LE, Kündig TM. Cutaneous Corynebacterium infection presenting with disseminated skin nodules and ulceration. Case Rep Dermatol. 2017;9(2):8–12.
6 Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):147–59.
7 Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, et al. Trimethoprim-Sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374(9):823–32.
8 Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, et al. A placebo- controlled trial of antibiotics for smaller skin abscesses. N Engl J Med. 2017;376(26):2545–55.
9 Piso RJ, Käch R, Pop R, Zillig D, Schibli U, Bassetti S, et al. A cross-sectional study of colonization rates with methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum Beta-Lactamase (ESBL) and carbapenemase-producing Enterobacteriaceae in four Swiss refugee centres. PloS one. 2017;12(1):e0170251.
10 Durupt F, Mayor L, Bes M, Reverdy ME, Vandenesch F, Thomas L, et al. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Br J Dermatol. 2007;157(6):1161–7.
11 Hanitsch LG, Krüger R, Hoppe PA, Humme D, Pokrywka A, Niebank M, et al. Outpatient decolonization after recurrent skin infection with Panton-Valentine leukocidin (PVL)-producing S. aureus – The importance of treatment repetition. PloS one. 2020;15(4):e0231772.
12 Sakr A, Brégeon F, Mège JL, Rolain JM, Blin O. Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections. Front Microbiol. 2018;9:2419.
13 Shallcross LJ, Fragaszy E, Johnson AM, Hayward AC. The role of the Panton- Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infectious Dis. 2013;13(1):43–54.
14 Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer AF. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol. 2008;29(6):510–6.
15 Miller LG, Eells SJ, Taylor AR, David MZ, Ortiz N, Zychowski D, et al. Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clin Infect Dis. 2012;54(11):1523–35.
16 Widmer AF, Zanetti G. Swiss-NOSO: Nosokomiale Infektionen und Spitalhygiene: Aktuelle Aspekte. 2007;13(2):7–11.